Figure 4.
Neuroprotective strategies need not only to consider the neurodegenerative loss of RGCs, but also neurovascular and neuroinflammatory components.
Neuroprotective strategies need not only to consider the neurodegenerative loss of RGCs, but also neurovascular and neuroinflammatory components.